Wound Care

Latest News

Mallinckrodt Receives FDA Label Update for StrataGraft Xenotransplantation Requirements
Mallinckrodt Receives FDA Label Update for StrataGraft Xenotransplantation Requirements

September 11th 2023

The FDA no longer restricts the donation of human cells, tissues, cellular or tissue-based products, human milk, ova, sperm, or organs for transplantation for patients who receive StrataGraft.

POLL: Do Your Treat Burns in Your Practice/Clinic?
POLL: Do Your Treat Burns in Your Practice/Clinic?

July 3rd 2023

Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE

June 24th 2023

Study Suggests Bovine Sialoglycoproteins Could Be Effective in Anti-Aging, Wound Healing
Study Suggests Bovine Sialoglycoproteins Could Be Effective in Anti-Aging, Wound Healing

June 16th 2023

Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe
Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe

June 7th 2023

Video Interviews
Podcasts
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

More News

© 2023 MJH Life Sciences

All rights reserved.